215 related articles for article (PubMed ID: 1682306)
1. Neurochemistry of bulimia nervosa.
Kaye WH; Weltzin TE
J Clin Psychiatry; 1991 Oct; 52 Suppl():21-8. PubMed ID: 1682306
[TBL] [Abstract][Full Text] [Related]
2. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.
Kaye WH; Weltzin TE
J Clin Psychiatry; 1991 Dec; 52 Suppl():41-8. PubMed ID: 1752859
[TBL] [Abstract][Full Text] [Related]
3. Research update on serotonin function in bulimia nervosa and anorexia nervosa.
Wolfe BE; Metzger E; Jimerson DC
Psychopharmacol Bull; 1997; 33(3):345-54. PubMed ID: 9550877
[TBL] [Abstract][Full Text] [Related]
4. [Selected issues of biological aspects of eating disorders].
Włodarczyk-Bisaga K; Bisaga A
Psychiatr Pol; 1994; 28(5):579-91. PubMed ID: 7991711
[TBL] [Abstract][Full Text] [Related]
5. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.
Naessén S; Carlström K; Byström B; Pierre Y; Hirschberg AL
Psychoneuroendocrinology; 2007 Jun; 32(5):548-54. PubMed ID: 17475412
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic dysfunction across the eating disorders: relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology.
Monteleone P; Brambilla F; Bortolotti F; Maj M
Psychol Med; 2000 Sep; 30(5):1099-110. PubMed ID: 12027046
[TBL] [Abstract][Full Text] [Related]
7. Brain monoamines and peptides: role in the control of eating behavior.
Leibowitz SF
Fed Proc; 1986 Apr; 45(5):1396-403. PubMed ID: 2869977
[TBL] [Abstract][Full Text] [Related]
8. Impaired cholecystokinin secretion in bulimia nervosa.
Geracioti TD; Liddle RA
N Engl J Med; 1988 Sep; 319(11):683-8. PubMed ID: 3412386
[TBL] [Abstract][Full Text] [Related]
9. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa.
Monteleone P; Martiadis V; Rigamonti AE; Fabrazzo M; Giordani C; Muller EE; Maj M
Biol Psychiatry; 2005 Apr; 57(8):926-31. PubMed ID: 15820714
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa.
Fava M; Copeland PM; Schweiger U; Herzog DB
Am J Psychiatry; 1989 Aug; 146(8):963-71. PubMed ID: 2568763
[TBL] [Abstract][Full Text] [Related]
11. The role of serotonin in eating disorders.
Leibowitz SF
Drugs; 1990; 39 Suppl 3():33-48. PubMed ID: 2197074
[TBL] [Abstract][Full Text] [Related]
12. [The role of serotonin in normal appetite regulation and in the pathogenesis of anorexia/bulimia].
Spigset O
Nord Med; 1990; 105(11):292-7. PubMed ID: 2251105
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic digoxin, hemispheric chemical dominance, and eating behavior.
Kurup RK; Kurup PA
Int J Neurosci; 2003 Aug; 113(8):1127-41. PubMed ID: 12888426
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between eating disorders and sleep disturbances].
Eiber R; Friedman S
Encephale; 2001; 27(5):429-34. PubMed ID: 11760692
[TBL] [Abstract][Full Text] [Related]
15. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
Frank GK; Kaye WH; Ladenheim EE; McConaha C
Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153
[TBL] [Abstract][Full Text] [Related]
16. Micro- and macroanalyses of patterns within a meal in anorexia and bulimia nervosa.
Sunday SR; Halmi KA
Appetite; 1996 Feb; 26(1):21-36. PubMed ID: 8660030
[TBL] [Abstract][Full Text] [Related]
17. What's New in the Treatment of Anorexia Nervosa and Bulimia?
Sobel SV
Medscape Womens Health; 1996 Sep; 1(9):5. PubMed ID: 9746643
[TBL] [Abstract][Full Text] [Related]
18. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
Kaye WH; Berrettini W; Gwirtsman H; George DT
Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
[TBL] [Abstract][Full Text] [Related]
19. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
[TBL] [Abstract][Full Text] [Related]
20. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
Ressler KJ; Nemeroff CB
Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
